Greiner Bio-One invests 9.3 million euros in expansion at Kremsmünster

Expanding the headquarters of Greiner Bio-One in Kremsmünster will almost triple available office space and help improve both cooperation and communication within the organization. The expansion indicates the potential for future growth at Greiner Bio-One. The groundbreaking ceremony was held on July 1, 2016, and construction is scheduled for completion in August 2017. Kremsmünster, July... Read more

Cellular Dynamics to Host Annual iForum™ Meetings Focused on Differentiated Human iPS Cell Innovations and Applications

Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells... Read more

BIO and Nikon Instruments Inc. Jointly announce a new Program for Research Grade Microscope System for BIO Members

WASHINGTON, June 29, 2016 (GLOBE NEWSWIRE) — The Biotechnology Innovation Organization (BIO) and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.  Nikon Instruments is a world-renowned market leader in optical instrumentation and research microscope systems known for cutting edge digital imaging technology for biomedical research solutions.As a supplier partner,... Read more

Fill, ventilate and achieve optimum growth

The CELLdisc cell culture vessel offers large growth surfaces on a small footprint and facilitates the scale-up of mass cell cultures. Greiner Bio-One, a technology partner for the diagnostic and pharmaceutical industry, presents CELLdisc, a new multilayer cell culture vessel that offers a growth area of up to one square metre for adherent mammalian cells... Read more

Sentinel Pancreatic Amylase Press Release

Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields   Forgot your password? Please provide the email address and your last name associated... Read more

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells

Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived Cells – Cellular Dynamics International Read more

New: The MACSPlex Exosome Kit, human from Miltenyi Biotec

AUTOMATED CHARACTERIZATION OF TINY VESICLES BERGISCH GLADBACH, June 21, 2016 – Miltenyi Biotec has extended its portfolio with the MACSPlex Exosome Kit, human. The fast and efficient process enables the characterization of 37 exosome surface markers in a single experiment. Studies indicate that the physiological significance of exosomes is not to be ignored. The molecular... Read more

Cellular Dynamics Appoints Derek Hei, Ph.D., as Vice President of Clinical Manufacture, Quality, and Regulatory Activities to Build Additional Capabilities for the Development and Manufacture of iPSC-Derived Cell Therapies

Cellular Dynamics Appoints Derek Hei, Ph.D., as Vice President of Clinical Manufacture, Quality, and Regulatory Activities to Build Additional Capabilities for the Development and Manufacture of iPSC-Derived Cell Therapies – Cellular Dynamics International Read more

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma

Takara Bio enters into a license and supply agreement of RetroNectin® with Kite Pharma Kusatsu/Shiga, Japan — June 21, 2016 – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with Kite Pharma, Inc. (“Kite”), United States, under which Takara Bio grants Kite a commercial license to use applicable patents relating... Read more